Citalopram and Fluoxetine in Major Depression Thierry BougerolJean-Claude ScottoHans Erik Høpfner Petersen Clinical Use 28 August 2012 Pages: 77 - 89
Bleeding Pattern, Endometrial Histology and Efficacy of Transdermal Estradiol and Sequential Estradiol/Norethisterone Acetate H. A. I. M. van LeusdenA. H. J. A. M. van BuurenJ. Pryse-Davies Clinical Use 28 August 2012 Pages: 90 - 97
Coronary Heart Disease Risk Factors and LDL Cholesterol-Lowering Efficacy of Fibrates and Simvastatin Erik MulsPhilippe AutierGreet Vansant Clinical Use 28 August 2012 Pages: 98 - 108
Impact of a Low-Dose Reserpine/Thiazide Combination on Left Ventricular Hypertrophy Assessed with Magnetic Resonance Tomography and Echocardiography Heinz Joachim HornKlaus DetmarGottfried Weidinger Clinical Use 28 August 2012 Pages: 109 - 116
Sustained-Release Isosorbide-5-Mononitrate Improves Exercise Capacity 30 Minutes after Oral Application J. GuzikM. KanopkaJ. Stepien Clinical Pharmacodynamics 28 August 2012 Pages: 117 - 124
Dual Effects of Bezafibrate on Lipid Metabolism and Hepatobiliary Enzymes Yoshihiro FukuoShinichi TakagiAkiro Terashi Clinical Pharmacodynamics 28 August 2012 Pages: 125 - 131
Cost Analysis of Infusion versus Injection Delivery of Imipenem/Cilastatin and Meropenem Richard J. Plumridge Clinical Pharmacoeconomics 28 August 2012 Pages: 132 - 136
Comparative Bioavailability of Sustained-Release Morphine Sulfate Capsules versus Pellets Alan BroomheadRaelene WestJeffrey Malick Pharmacokinetics 28 August 2012 Pages: 137 - 145
Fluvastatin Lipid-Lowering Effect in Routine Practice Conditions (FLIRT) Stefan BeilConrad PfafferottMichael Weber Pharmacovigilance 28 August 2012 Pages: 146 - 153
Beneficial Effect of Verapamil in the Elderly and Patients with Increased Cardiovascular Risk Christian M. Jespersen Correspondence 28 August 2012 Pages: 154 - 155
